Zurich Cantonal Bank’s Pliant Therapeutics PLRX Stock Holding History

Zurich Cantonal Bank’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41	Hold	36	–	–	﹤0.01%	2535
2026 Q1	$45	Buy	+36	New	+$45	﹤0.01%	2528
2025 Q4	–	Sell	-606	Closed	-$910	–	3271
2025 Q3	$897	Sell	606 -265	-30%	-$404	﹤0.01%	2528
2025 Q2	$1.01K	Sell	871 -8,123	-90%	-$11.5K	﹤0.01%	2541
2025 Q1	$12.1K	Buy	8,994 +964	+12%	+$5.85K	﹤0.01%	2581
2024 Q4	$106K	Hold	8,030	–	–	﹤0.01%	2412
2024 Q3	$90K	Hold	8,030	–	–	﹤0.01%	2456
2024 Q2	$86.3K	Hold	8,030	–	–	﹤0.01%	2432
2024 Q1	$120K	Buy	8,030 +2,430	+43%	+$40.1K	﹤0.01%	2311
2023 Q4	$101K	Sell	5,600 -1,854	-25%	-$28.2K	﹤0.01%	2444
2023 Q3	$129K	Hold	7,454	–	–	﹤0.01%	2226
2023 Q2	$135K	Buy	7,454 +1,229	+20%	+$29.1K	﹤0.01%	2176
2023 Q1	$166K	Hold	6,225	–	–	﹤0.01%	1998
2022 Q4	$120K	Buy	+6,225	New	+$130K	﹤0.01%	2162

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Zurich Cantonal Bank's PLRX Position: Q2 2026 in Review

Zurich Cantonal Bank held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 36 shares worth $41. The position accounts for ﹤0.01% of the portfolio, ranked #2535.

Zurich Cantonal Bank first reported a position in PLRX in Q4 2022 and has held it in 14 quarters since. The position peaked at $166K in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Zurich Cantonal Bank held 36 shares of Pliant Therapeutics worth $41 as of Q2 2026.
Zurich Cantonal Bank left its Pliant Therapeutics share count unchanged in Q2 2026.
Pliant Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2535 holding.
Zurich Cantonal Bank first reported a position in Pliant Therapeutics in Q4 2022 and has held it in 14 quarters since.
Zurich Cantonal Bank's Pliant Therapeutics position peaked at $166K in Q1 2023.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.